MAPT and Alzheimer disease: In both the 3xTG AD and APP/PS1/Tau AD models, the hippocampal area was the primary brain region where the contrast effect of the oligomeric amyloid-β targeted contrast agent was observed, with varying patterns of contrast effect depending on the model.